SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-022488
Filing Date
2022-11-07
Accepted
2022-11-07 13:21:26
Documents
16
Period of Report
2022-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fate-20221107.htm   iXBRL 8-K 59551
2 EX-10.1 fate-ex10_1.htm EX-10.1 25149
3 EX-99.1 fate-ex99_1.htm EX-99.1 21752
4 GRAPHIC img158830969_0.jpg GRAPHIC 19733
5 GRAPHIC img240522552_0.jpg GRAPHIC 3340
  Complete submission text file 0000950170-22-022488.txt   262355

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fate-20221107_lab.xml EX-101.LAB 12806
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fate-20221107.xsd EX-101.SCH 2493
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fate-20221107_pre.xml EX-101.PRE 9469
10 EXTRACTED XBRL INSTANCE DOCUMENT fate-20221107_htm.xml XML 4520
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36076 | Film No.: 221364675
SIC: 2836 Biological Products, (No Diagnostic Substances)